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Abstract 
Tracheomalacia, stenosis and other traumatic airway injuries (e.g., obstructive tracheobronchial 
tumors) often require airway stenting. Traditional polymeric stents are prone to cause infection, 
do not ‘grow’ with a child and often require surgical removal. Therefore, resorbable biometallics 
are ideal materials for tracheal stent devices.  Magnesium (Mg) is an attractive material because 
of its biocompatibility, abundance within the human body, and intrinsic corrosive nature can be 
overcome via alloying elements. We hypothesize that resorbable magnesium-based materials can 
be utilized for the development of tracheal stents. The objective of the present study was to 
determine cytocompatibility of Mg alloys with fully differentiated cultures of normal human 
bronchial epithelial (NHBE) cells to simulate an in vivo response.  Confluent cultures of 
differentiated NHBE cells were exposed to wires of high purity Mg or novel MgZnCa alloy for 
0,4,18, 24, and 48 hours.  Endpoint assays included reverse transcriptase PCR, western blot 
analysis, and ELISA to assess modulation of cellular responses such as regulation of 
inflammatory mediators and mucus secretion; wire corrosion was evaluated via scanning 
electron microscopy.  A wound repair assay was performed to evaluate the effect of wires on cell 
proliferation. One-way analysis of variance (ANOVA) and Bonferroni post-test corrections (p-
value<0.05) were performed to detect differences among means.  Wires of MgZnCa did not elicit 
inflammation, inhibit cell proliferation or migration; and degraded less than Mg wires. These 
findings suggest MgZnCa alloy may be an acceptable biomaterial to use in the application of 
tracheal stents; however, further analysis is required to determine long-term stent-airway 
dynamics
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CHAPTER 1 
Introduction 
Airway obstruction, caused by tracheal stenosis or tracheomalacia (especially in children and 
infants), is a pressing problem that requires an involved solution. For these ailments, common 
treatments range from balloon dilations to traditional surgical treatments (including the 
stabilization of airway lumen through implanting a metallic or silicone stents) to invasive 
surgical procedures (slide tracheoplasty in children or surgical resection of the trachea with 
primary reconstruction).   The use of metal stent implants has been met with controversy due to 
the physiological and technical difficulties associated with toxicity and inflammation; however, 
some benefits have been attained (Michel, 2000). Development of obstructive granulation tissue 
(Pahl, 1999), possible toxicity due to corrosion or leaching (Poynter, 2003), recovery difficulties 
(Patel, 2006) and lack of biocompatibility (Yuen, 2010) have been reported as the major issues 
encountered with the use of metallic stents. Even though the challenges of metallic stent use 
seem insurmountable, their benefits outweigh their inadequacies. Metallic stents have been found 
to provide smaller migration rates, add conformity to abnormal airways, increase cross-sectional 
airway diameters, and add inner stent epithelialization enabling mucociliary clearance (Patel, 
2006). The research in this project is therefore important as it is evident that metallic stents are 
valuable tools in the treatment of airway strictures, but so far, the ideal stent has yet to be 
designed. 
1.1 Magnesium’s functions and biocompatibility in the human airway.  
The long-term goal is to utilize magnesium (Mg) alloys for resorbable tracheal stent 
devices.  Magnesium is an attractive material because of its biodegradability and 
biocompatibility. Magnesium is an essential divalent intracellular cation that plays a pivotal role 
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in daily physiological functions within the body.  In fact, magnesium is necessary for the 
synthesis of nucleic acids and proteins, and is critical in the production and function of various 
enzymes and transporters (Poynter, 2003). There are approximately 22-26 grams (1 mole) of 
magnesium within the adult human body and it is the fourth most abundant cation (Adcock, 
2006). Mg also has important effects on the body’s cardiovascular system (Adcock, 2006), as 
well as modulation of neuromuscular transmissions (Jones, 2004). Additionally, Mg does not 
inhibit cell growth and enhances bone cell adhesion (Yuen, 2010). Magnesium, along with 
calcium, act in concert within the human airway to control smooth airway muscle 
(Gourgoulianis, 2001). The electroneutral calcium efflux pump found in the plasma membrane of 
most cells including airway smooth muscle, is a magnesium and ATP dependent enzyme, which 
extrudes one calcium ion for two hydrogen ions (Knox, 1995). It is stimulated by calcium-
calmodulin complex that may act as a feedback mechanism to limit the rise in intracellular 
calcium following stimulation (Knox, 1995). Although magnesium is subject to corrosion, its 
corrosion resistance can be improved by alloying it with other less corrosive metals such as 
titanium or zinc.  
1.2 Innovation.  
The goal of this study is to evaluate cell physiology and cytotoxic potential of NHBE 
cells following exposure to magnesium alloy wires. An air-liquid interface (ALI) cell culturing 
system is used as a model because NHBE cells maintained in this manner are essentially 
identical to tracheal epithelial cells in vivo with respect to structure and function. In addition, this 
model reduces the occurrence of magnesium corrosion due to the lack of wire submersion in the 
cell culture medium.  
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1.3 Applications of Biomaterials.  
The field of tissue engineering and regenerative medicine has increased greatly due to the 
development and incorporation of biocompatible and bioactive materials. More specifically, 
biomaterials have contributed to this growth due to their dynamic properties useful in various 
applications such as wound healing, drug delivery (Zhang, 2010) and tissue scaffolds (Kumar, 
2009).  However, in order for this revolution to continue, the safety and toxicity of these novel 
materials must be properly investigated. This study will evaluate the efficacy of magnesium alloy 
wires as a material for scaffolding in the development of biodegradable tracheal stents. 
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CHAPTER 2 
Literature Review 
 Diseases that affect the trachea such as congenital tracheomalacia (in infants), tracheal 
stenosis and other obstructive airway disorders caused by injury, all require a complex solution. 
Currently there are permanent stents that often require surgical insertion and removal (Purnama, 
2010). A novel alternative to these permanent stents are biodegradable, biocompatible, biometal 
stents. Precise knowledge about tissue-implant interactions, tissue engineering, regenerative 
medicine as well as recent advances in cell and molecular biology have given rise to the new 
concept of bioactive materials. Unlike conventional inert biometals, bioactive materials are 
supposed to promote positive interactions with physiological implantation sites (Purnama, 2010). 
 Degradable biomaterials constitute a novel class of highly bioactive biomaterials that are 
expected to support the healing process of a diseased tissue or organ and subsequently degrade at 
a rate proportional to regeneration. Studying novel degradable biomaterials is currently one of 
the most interesting research topics in biomaterials. Advances in materials science and 
engineering, in particular concerning processing and thermomechanical treatment, allow the 
properties of these structural materials to be tailored for specific applications (Purnama, 2010). 
The demand for biomaterialists to develop new technologies and provide better implants with 
higher clinical performance has been substantially increased by the ever-aging society and a push 
for a better quality of life. The old paradigm that states implants must be inert and corrosion 
resistant has been shifted via the introduction of this new class of biomaterials. This set includes 
two classes of materials identified by the term “permanent” and “degradable” in reference to 
corrosion resistant biomaterials. 
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 Biodegradable biomaterials have been proposed since 1988 including polymers such as 
poly-L-lactic-acid (PLLA), polyglycolic acid/polylactic acid and polycaprolactone. The research 
for degradable magnesium alloys and related materials started in the 1900’s and 1920’s (Yuen, 
2010).  In 1938 magnesium was used in a degradable metallic material (DMM) to fix bone 
fractures (Purnama, 2010); however, the main issue with DMM’s is that they induce local or 
systemic toxicity (Purnama, 2010). In spite of the vast potential of magnesium biometals, rapid 
degradation rates may impose severe limitations in clinical applications thus necessitating 
incorporation of biocompatible alloying elements (Xin, 2011). A brief summary of current 
literature related to respiratory pathology, magnesium biocompatibility and airway stenting is 
presented here. 
2.1 The Respiratory System and Tracheal Pathophysiology 
 The process of metabolism in the human body consumes oxygen and produces the waste 
product carbon dioxide. The cardinal function of the respiratory system is to exchange the carbon 
dioxide accumulated in the blood for oxygen in the airways via the nose, pharynx, larynx, 
trachea and bronchi.  
There are two functional components of the respiratory system: the conducting zone and 
the respiratory zone. The conducting zone works to bring air into the lungs and exists both 
outside and inside the lungs. Components of the conducting zone are the nose, pharynx, larynx, 
trachea, bronchi and the bronchioles. The respiratory zone is the site of gas exchange and 
consists of the respiratory bronchioles, alveolar ducts, alveolar saccules and alveoli (Gray, 1918). 
The ribcage is an airtight cylinder with the diaphragm as the base and the root of the neck as the 
top lid. Inspiration (inhalation) is always an active process mainly involving muscular 
contraction of the diaphragm and intercostals muscles (Marieb, 2010). Expiration is typically a 
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passive process caused primarily by elastic recoil of the diaphragm and relaxation of the 
intercostals muscles. 
The trachea descends from the larynx through the neck and into the mediastinum and 
ends by dividing into the two main bronchi at mid thorax and enters the lungs. The trachea is 
chiefly a stack of horseshoe (or “C”) shaped cartilaginous rings that are connected to each other 
by fibrous tissue, forming a “gutter” opening at the backside that is closed by the trachealis 
muscle that connects to the ends of the “C” shaped rings. The number of cartilage rings in the 
trachea can vary from sixteen to twenty in number. Each ring forms an imperfect circle and 
measures about 4mm in depth and 1mm in thickness. These cartilages are stacked on top of each 
other horizontally and separated by narrow intervals. Their outer surfaces are flattened in a 
vertical direction; however, being thicker in the middle than at the margins, they are internally 
convex. The cartilages remain highly elastic in early and mid-life but, may become calcified in 
advanced life (Gray, 1918).  
The trachea is about 10-12cm long, approximately 2cm in diameter, very flexible and 
mobile. The walls consist of the mucosa, submucosa, adventitia and a layer of hyaline cartilage. 
The mucosa is lined with goblet cell containing pseudostratified epithelium that is prevalent in 
most of the respiratory tract. The cilia are essential as it persistently sweeps debris-laden mucus 
toward the pharynx. The submucosa is composed of a network of loose connective tissue that 
contains large blood vessels, nerves and mucous glands; the ducts of the aforementioned overlay 
layers and open on the surface and  help produce mucus “sheets” in the trachea. The submucosa 
is located deep to the mucosa.  The submucosa is supported by sixteen to twenty “C” shaped 
rings of hyaline cartilage encased by the adventitia that is the outermost layer of connective 
tissue. 
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 The elasticity of the trachea makes it flexible enough to stretch during inspiration and 
recoil during expiration. Tracheal rings prevent the trachea from collapsing and keep the airway 
patent despite pressure changes that occur during breathing. The trachealis muscle connects the 
open posterior parts of the cartilage rings that lie alongside the esophagus. Since this portion of 
the trachea is not rigid the esophagus can expand anteriorly so that swallowed food can move 
through. When the trachealis muscle contracts it decreases the diameter of the trachea and forces 
expired air to rush upward from the lungs with greater force (cough). The final tracheal cartilage 
is called the carina. The carina is thick and broad in the middle and projects posteriorly from its 
inner face, marking the point where the trachea branches into the two main bronchi. The mucosa 
of the carina is very sensitive and in the presence of foreign objects causes violent coughing. 
When inhaled air reaches the end of the trachea it is clean, warm and saturated with water vapor. 
 2.1.1 Tracheal Obstruction 
 Since the trachea is the normal route for air entry into the lungs, tracheal obstruction is 
life threatening. Pulmonary irritant reflexes respond to inhaled irritants in the nasal passages or 
trachea by causing reflexive bronchoconstriction in the respiratory airways (Marieb, 2010). 
Tracheal obstruction can be caused by a myriad of threats. Infants up to 2-3 months of age are 
obligatory nose breathers and are unable to breathe in through their mouth; therefore, nasal 
congestion in infants is severe. Tracheobronchial cartilaginous rings of the young child can 
collapse easily, such that external compression or a slight increase in negative force will cause 
tracheal collapse (Hoffer, 1994).  
Tracheomalacia, on the other hand, is described as weakness of the cartilaginous rings of 
the trachea. Tracheomalacia is encountered in both pediatric and adult medicine.  Malacia, in 
medical terminology, is described as “a morbid softening or softness of a tissue or part” 
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(Leonard, 1997). The softness generally refers to bone or in this case the cartilage of the trachea. 
Tracheomalacia is typically due to a reduction and/or atrophy of the longitudinal elastic fibers of 
the pars membranacea or impaired cartilage integrity such that the airway is softer and more 
susceptible to collapse.  
 Tracheal stenosis is characterized by structural tracheal constriction. It presents in long or short 
segments and is associated with pulmonary, cardiovascular and gastrointestinal malformations 
(Ho, 2008). In infants tracheal stenosis is typically congenital; in adults however; stenosis can be 
caused by trauma, a chronic inflammatory disease, a benign or malignant neoplasia or a collagen 
vascular disease (Carden, 2005). Events leading to stenosis in adults include; ulceration of the 
mucosa and cartilage, inflammatory reactions with associated granulation tissue, fibrous tissue 
formation and contraction of fibrous scar tissue (Carden, 2005). Healing of ulceration (the 
earliest of laryngotracheal injury that is produced by an enodotracheal tube) involves 
regeneration of the epithelium (primary healing) or repair (secondary healing). If the granulation 
tissue is not covered by regenerated epithelium, then the granulation tissue will become 
exaggerated (Carden, 2005). Granulation tissue which is, new connective tissue and tiny blood 
vessels that form on the surfaces of a wound during the healing process, may be the most 
common problem and risks obstructing already unstable, narrowed lumen (Ho, 2008).  
2.2 Current Airway Stents 
Current trends in airway repair include a large facet of repair techniques. 
Tracheobronchial prostheses or airway stents are used to palliate the effects of large airway 
obstruction (Saito, 2005).  Airway stenting can be complementary to open surgical treatment in 
some settings and may replace the need for surgery completely. In patients with airway 
obstruction caused by advanced malignant disease, airway stenting can produce a gratifying 
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improvement in quality of life and prevent death from an obstructed airway (Saito, 2005). A 
variety of stents have been studied experimentally and/or used clinically to aid in the 
management of complex tracheal, cranial and bronchial stenoses (Jacobs, 2000). Airway stents 
resemble finger cuffs initially; they are small, intricate devices that are pleasing to the eye but 
have potential for unforeseen complications. These stents have gained increasing popularity in 
the management of difficult airway obstructions based on the simplicity of their placement and 
the lack of good alternative approaches. Also, careful and judicious stent placement has provided 
significant and life-saving airway improvement in many patients (Zakaluzny, 2003). 
In general, airway stents can be classified into one of four categories; silicone, balloon 
dilated metal stent, self-expanding metal stent and covered self-expanding metal stent (Chin, 
2008). Silicone stents are derived from the Montgomery T-tube originally described in the 
1960’s (Chin, 2008).  The T-tube design has been modified by several pulmonologists and 
surgeons creating the Dumon, Hood, Reynders, Dynamic and Polyflex subtypes (Figure 1). In 
contrast to the silicone stents, early metal airway stents were developed from endovascular stent 
technology (Figure 2). The metal is usually stainless steel, cobalt- alloys, titanium-alloys and/or 
nitinol (Xin, 2008). The most common complications associated with airway stents are migration 
of the stent, granulation tissue formation around the stent and diminished mucociliary clearance, 
poor patient tolerance, problems with placement and removal. Therefore, the biodegradable stent 
proposed in this research study is a necessary first step toward addressing these complications. 
Migration is one of the most frequent complications associated with the use of stents, it is 
essentially vital that the stent remains stationary after being placed. Silicone stents are more 
prone to migration and may even be expelled. Migration is less common in metallic stents 
because of the method of deployment used and the inherent properties of the stent. 
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Figure 1 Current silicone airway stents. (A) Montgomery T-tube (Healthcare, 2013), (B) Dumon 
Silicone tubes (Novatech, 2013), (C) Hood silicone stent (Medical, 2013),( D) Reynders silicone 
stent (Noppen, 1999), (E) Dynamic silicone stent (Rafanan, 2000) and (F) Polyflex silicone stent 
(Theodore, 2009) . 
Figure 2 Metallic Stents (Rafanan, 2000). (A) Strecker balloon stent at different stages of 
deployment, (B) Gianturco-Z self-expanding stent, (C) covered and uncovered wallstent. 
13 
 
 Metal stents are generally placed in a collapsed position and then expanded to achieve as much 
of a custom fit as possible (Zakaluzny, 2003). In comparison, silicone stents are usually folded 
and released in place to expand to their preformed shape. Thus, the metal stent is firmly seated 
and its silicone counterpart is only as well positioned as its predetermined diameter and length 
allows (Zakaluzny, 2003). There is less migration with longer metallic stents compared with 
silicone stents or short metallic stents (Saito, 2005). 
Granulation tissue formation is a common complication that is prone to the proximal and 
distal ends of the stent. Excessive granulation tissue can lead to obstruction of the airway 
(trachea) (Saito, 2005). Granulation tissue formation may be mild enough to remain 
asymptomatic, moderate enough to produce stridor and severe enough to lead to life-threatening 
respiratory distress (Zakaluzny, 2003). Complications with granulation tissue are more common 
with metallic stents than those made of silicone. Similar to migration, the reasons for more 
granulation tissue formation are inherent to the properties of the metallic stent. The rigidity of 
metal stents cause more irritation in the airway, the edges of metal stents place circumferential 
pressure on the tissue and subsequently lead to the formation of granulation tissue. In addition to 
causing airway obstruction, granulation tissue can become a medium for bacterial growth 
(Zakaluzny, 2003). 
Inhibition of mucociliary mechanisms that clear the airway of secretion is another 
complication resulting from the use of airway stents.  The mesh design of metallic stents helps to 
preserve mucociliary function (Chin, 2008). Unlike their silicone counterparts, metal stents 
permit mucosalization—integration with the tracheal wall—through their interstices thereby 
allowing adequate mucociliary clearance (Zakaluzny, 2003). Silicone stents, because of their 
solid construction inhibits mucociliary clearance. Granulation tissue also has the capacity to 
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impair mucociliary clearance. Lack of mucociliary clearance can lead to airway obstruction and 
infection. 
In some instances patients are unable to tolerate stenting for long periods of time. In 
general, still, longer stents are not as well tolerated as short, flexible, compliant stents. Studies 
have shown that granulation complications are associated with tracheal stent placement (Koi, 
2009). Most of the complications occur in the laryngeal region and can be prevented by avoiding 
stenting over the subglottic region (Ko, 2009). 
Complications of placing and removing stents are common occurrences. At times the 
complication may be that the stent is simply unable to be placed. Stent placement may become 
difficult due to inherent airway disease, poor stent choice, inadequate stent sizing or lack of 
specific instrumentation (Zakaluzny, 2003).When patients experience complications from the 
metallic stents that cause airway injury or obstruction it may become necessary to remove the 
stent (Lunn, 2005). Complications associated with removal of stents are much more common. 
Stent epithelialization in conjunction with granulation tissue formation around metal stents can 
make their removal very difficult or nearly impossible in some cases (Zakaluzny, 2003). Given 
that metal stents typically become mucosalized within one month of placement they are regarded 
as permanent fixtures. If stent removal is necessary, they may have to be deconstructed and 
removed piece by piece (Zakaluzny, 2003). Removal of metallic airway stents is also associated 
with significant complications, health-care resources use and costs (Alazemi, 2010). 
The ideal stent will combine the advantages of silicone and metallic stents. Silicone stents 
tend to disturb airway mucociliary clearance and migrate. Metallic stents on the other hand are 
semi permanent fixtures and should not be used in children because they will not grow as the 
child grows (Saito, 2005). They also cannot degrade spontaneously and a second surgical 
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procedure is needed to remove the metal stent from the body (Xin, 2008). Repeated surgery 
increases the cost as well as patient morbidity. In this respect biodegradable Mg based alloys 
could be a potential solution. Hence, proceeding with research to characterize, model and 
produce biodegradable options for airway stents may provide definite alternatives to surgical 
intervention for both malignant and benign airway stenosis in the future. 
2.3 Magnesium Biocompatibility 
 Magnesium (Mg) biocompatibility is a key factor in this study. Mg and its alloys have 
been investigated as early as 1878 for their potential use as a biomaterial (Kirkland, 2012). It’s 
present in high concentrations in sea water and is the eighth most abundant element on Earth. Mg 
also has excellent specific strength and low density (Alvarez-Lopez, 2010).  It is the fourth most 
abundant cation in the human body and is largely found in bone tissue as its presence is 
beneficial to bone strength and growth (Purnama, 2010). Mg is vital to metabolic processes, a co-
factor in many enzymes, stabilizes the structure of DNA and RNA and a key component of 
ribosomal machinery that translates the genetic information encoded by mRNA into polypeptide 
structures (Xin, 2011).  Mg deficiency is reported to cause cell membrane dysfunction, an 
increased incidence of cancer, heart disease and susceptibility to oxidative stress. On the other 
hand, excess magnesium can lead to muscular paralysis, hypotension, respiratory distress and 
cardiac arrest; all found to be unlikely because of efficient filtration by the kidneys. In vitro and 
in vivo studies have shown that Mg alloys possess good biocompatibility. Mg and its alloys have 
been used in applications such as bone implants because their density is similar to natural bone 
and more adequate mechanical properties (Alvarez-Lopez, 2010). There are studies that have 
shown that dissolved Mg ion may promote cell attachment and tissue growth on implants (Xin, 
2008). 
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There are many actions of Mg that are potentially relevant to airway disease; the most 
obvious is the relaxation of smooth muscle. Gilbert et al. performed studies with vascular smooth 
muscle that showed this effect is dose dependent and mediated by competition with calcium 
entry through voltage and receptor operated channels on the cell membrane and by inhibition of 
intracellular calcium release from the sarcoplasmic reticulum (Gilbert, 1992). Magnesium has 
been shown to cause dose-related relaxation and inhibition of contraction induced by histamine, 
electrical field stimulation and cholinergic agonists in airway smooth muscle tissue (Britton, 
1994). This effect is mediated by calcium antagonism that may result in bronchodilation and 
reduction in the reactivity of the airway to inhaled bronchoconstrictor agents. These effects are 
likely to be complemented, by other actions of magnesium that cause bronchodilation and 
reduction in airway reactivity through indirect effects on airway smooth muscle via inhibition of 
cholinergic transmissions promotion of nitric oxide (NO) release, or through a reduction in 
airway inflammation through effects on prostacyclin production and mast cell and T-lymphocyte 
stabilization (Britton, 1994). High magnesium intake is associated with a decrease in the relative 
odds of airway hyper-reactivity, independent of generally recognized confounding factors, and of 
the major determinants of hyper-reactivity (Britton, 1994). Magnesium may have an independent 
effect which renders the airway less responsive to an inhaled bronchoconstrictor stimulus 
(Gilbert, 1992). It is therefore possible that differences in the availability of magnesium may 
result in differences in both airway reactivity and lung function. 
   Unfortunately the only limitation concerning Mg based biomaterials is their low 
corrosion resistance (Purnama, 2010). It has been reported that cyclic stresses (fatigue) related 
mechanisms are responsible for mechanical failures of implantable metallic components 
(Antunes, 2012). Metallic implants, like Mg based biometals, owe their resistance to the 
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formation of a stable, compact and continuous oxide surface film called passive film that 
prevents the underlying bare metal surface from coming into contact with theses aggressive ions 
(Antunes, 2012). However, the passive film can be locally dissolved generating pits that rapidly 
propagate leading to pitting corrosion. This corrosion can lead to critical fractures in a process 
called corrosion fatigue where there is failure of a material under the simultaneous action of 
cyclic loads and chemical attack (Antunes, 2012).  Fast degradation rates have also been 
considered a result of products in the physiological environment such as phosphates, chlorides, 
carbonates and sulfates (Xin, 2008). Also, hydrogen gas evolves during in vitro and in vivo 
degradation of Mg biometals. If degradation is too fast, hydrogen may accumulate as 
subcutaneous gas bubbles (Antunes, 2012) and not allow the body the amount of time necessary 
to regulate the gas created. Nevertheless, Mg based biometals produce mainly soluble and non-
toxic products. 
Controlling the corrosion rate of Mg based biomaterials is of paramount importance. 
Work to enhance corrosion resistance has been done such as coatings with dicalcium phosphate 
dehydrate (DCPD), alkali heat treatments and alloying.  Past alloying elements included 
aluminum (Al), manganese (Mn), zirconium (Zr) and rare earth (RE) metals because of their 
largely positive effect on the corrosion resistance of magnesium. Conversely, studies have shown 
that MgAl and MgRE systems should not be used because they cause harmful effects on 
osteoblasts as well as cytotoxicity on different cell lines and may even cause the onset of 
Alzheimer’s disease (Witte, 2008). Aluminum can bind to inorganic phosphate causing a lack of 
phosphate in the body leading to dementia (Lucey, 1977). Zirconium is closely associated with 
liver, lung, breast and nasopharyngeal cancers (Song, 2007). Even manganese has been proven to 
cause neurotoxicity that can lead to Parkinsonism (Crossgrove, 2004).  Since, new studies have 
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been done with other alloying elements such as calcium (Ca) and zinc (Zn) (Antunes, 2012). 
MgCa and MgZn alloys have not shown signs of cytotoxicity such as nitrosative or oxidative 
stress (Li, 2008; Yuen, 2010). In this study a MgZnCa alloy was used to test its efficacy for use 
in the scaffolding of tracheal airway stents. The Zn and Ca pair present in this alloy make it a 
more attractive alloy because it addresses the corrosion problem that is presented by Mg 
biomaterials in addition to diminishing potential cytotoxicity.  
2.4 Oxidative Stress 
 Since oxidative stress has been implicated in vascular, cardiac and tracheal stenosis, and 
cations may contribute this phenomenon, it is imperative to investigate the role of oxidant stress 
(if any) in tracheal stenosis in the presence of our MgZnCa alloy. Free radicals are chemical 
species that have a single unpaired electron in an outer orbit. Cell injury caused by free radicals 
is an important mechanism of cell damage in may pathologic conditions (Kumar, 2010). Those 
radicals derived from oxygen represent the most important class of such species generated in 
living systems (Valko, 2006).  When the production of reactive oxygen species (ROS) is 
increased or the scavenging systems are ineffective, the result is an excess of these free radicals, 
leading to oxidative stress (Kumar, 2010). Oxidative stress has been implicated in pathologic 
processes including cell injury, cancer, aging and some degenerative diseases. In the airway, 
ROS and reactive nitrogen species (RNS) cause hyper-responsiveness, airway inflammation in 
asthma and airway remodeling in humans and animals (Valko, 2006). 
ROS and reactive nitrogen species (RNS) are generated by radiation exposure (UV light, 
X-rays and gamma rays), inflammation (byproducts of neutrophils and macrophages), aging, 
metal catalyzed reactions (iron, copper, chromium, cobalt, vanadium, cadmium and nickel), 
endotoxic shock, byproducts of mitochondria-catalyzed electron transport reactions, present as 
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atmospheric pollutants and ischemia reperfusion of the heart, intestine, liver, kidney and brain 
(Kourie, 1998, Valko, 2006). ROS originate from both endogenous and exogenous sources.  
Possible endogenous sources include the electron transport system of mitochondria, cytochrome 
P450 metabolism, peroxisomes and inflammatory cell activation (Valko, 2006). Metabolic 
processes that produce ROS are the xanthine (X)/xanthine oxidase (XO) system, the 
cyclooxygenase pathway of the arachidonic acid metabolic system, the activated neutrophil 
system and the amyloid β protein system (Kourie, 1998). Exogenous sources may come from a 
being’s environment such as air pollution or medical insertion of foreign objects among other 
things. 
Reactive oxygen species (ROS) along with reactive nitrogen species (RNS) are well 
recognized for playing a dual role as being both a deleterious and beneficial species (Valko, 
2006). Radicals of ROS have important roles in physiological process including cell signaling 
and pathogen killing as a part of the immune system (Valko, 2006). Effects of ROS include 
physiological role in response to noxia; ROS at low concentrations is the induction of mitogenic 
response. On the contrary, high concentrations of ROS can be important mediators of damage to 
cell structures, including lipids and membranes, proteins and nucleic acids.  
 Superoxide anion (O2
-
) is created through metabolic processes or post oxygen activation 
by physical irradiation and is considered the primary ROS. This free radical has the ability to 
interact with other molecules and generate “secondary” ROS either directly or universally 
through enzyme- or metal-catalyzed processes (valko, 2006). On the other hand, superoxide 
radical does not react directly with polypeptides, sugars or nucleic acids and its ability to 
peroxidise lipids is controversial (Valko, 2006). Superoxide is inactivated by conversion to H2O2 
and O2 by Superoxide dismutase (SOD) in a dismutation reaction. The hydroxyl radical (
-
OH) is 
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highly reactive with a half-life of 1 ns forcing it to react close to its site of formation. Hydrolysis 
of H2O caused by ionizing radiation produces 
–
OH. In addition, production of 
–
OH near DNA 
can cause this radical to react with DNA bases or the deoxyribosyl backbone of DNA to 
produced damaged bases or strand breaks. The hydroxyl radical is neutralized via conversion to 
water by glutathione peroxidase. Singlet Oxygen (
1
O2) is the metastable excited site of triplet 
molecular oxygen, where which all electrons are paired.  It has been suggested that singlet 
oxygen is formed from the superoxide radical in the course of pyrimidine nucleotide oxidation.  
Singlet Oxygen is an important chemical and biological agent as it is involved in numerous 
chemical and biological processes (Weishaupt, 1976). Biologically, in the area of photodynamic 
reactions that involve modification or destruction of biological molecules and systems under the 
same oxidative conditions in many instances may also proceed via singlet oxygen pathways 
(Weishaupt, 1976). Singlet oxygen has been implicated in biological systems such as xanthine 
oxidase, linoleate-lipooxidase and NADPH-dependent microsome lipid peroxidation. 
Carotenoids are well established as singlet oxygen quenchers. Still, in complex biological 
systems, carotenoid protection alone may be insufficient (Weishaupt, 1976). Hydrogen Peroxide 
(H2O2) is generated by the enzyme SOD or directly by oxidases in intracellular peroxisomes. 
Hydrogen peroxide is considered a ROS because it readily reacts with biological material such as 
DNA, lipids and proteins (Waterman, 2008). H2O2 can be readily be converted to 
–
OH or OCl
-
 
(hypochlorite), which destroy microbes and cells. These ROS can act distantly from the site of 
activation (Kumar, 2010). SOD enzymes work in conjunction with H2O2 removing enzymes such 
as catalases and glutathione peroxidase (Valko, 2006). 
Reactive nitrogen species (RNS), in biological systems, are founded primarily by nitric 
oxide (NO). Reactions of NO ultimately lead to the oxidation, nitration (addition of NO2), 
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nitrosation (addition of NO), nitrosylation of most classes of biomolecules (Patel, 1999). NO has 
a dual functionality in oxidative stress where it a pro- and anti-inflammatory mediator. RNS are 
formed via enzymatic oxidation of L-arginine into NO by nitrogen oxide synthases (NOS) 
(Valko, 2006). Inducible nitric oxide synthase (iNOS) is one of three isoforms found in 
mammalian systems and is the only inducible form. Quantitation of the changes in iNOS may 
indirectly reflect NO levels. Nuclear Factor-kappa B (NF-κB) regulates inflammatory cytokines 
such as tumor necrosis factor alpha (TNF-α), interleukin-1 beta (IL-1β) and interferon gamma 
(IFN-γ), all of which induce iNOS expression (Murphy, 1999). Nitric oxide produced by iNOS 
can contribute to the cell death that may occur, however, necrosis is thwarted when free radicals 
are rapidly removed. 
To balance the harmful effects of ROS antioxidants take action. These antioxidants are 
non-enzymatic antioxidants that work in conjunction with antioxidant enzymes to bind to free 
radicals and hinder them from interactions with lipids proteins or DNA molecules (Valko, 2006).  
Important antioxidants in this study include superoxide dismutase (SOD) and glutathione S 
transferase (GST), a vital enzyme that contains a “family” of nine enzymes that aide in 
detoxification.  These enzymes speed up the linking of toxic compounds to the “master” 
antioxidant glutathione (GSH). Super oxide dismutase works by dismuating the superoxide anion 
to H2O2 and O2. 
2.5 Hypothesis and Objectives 
At this time, the specific effect of a magnesium zinc calcium alloy on tracheal epithelia is 
unknown. Currently, degradable magnesium alloys are being held as promising biomaterials for 
applications in orthopedic and trauma surgery (Zhang, 2010).  Research suggests that magnesium 
oxide (MgO), in the form of nanoparticles, are soluble in the epithelial lining fluid of the lungs 
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that reduces irritation and health effects consequences (Feng, 2011). Magnesium alloys 
containing calcium polyphosphate particles have been found to have good mechanical properties 
and controlled degradation (Feng, 2011). Additionally, Mg did not inhibit cell growth and 
enhanced bone cell adhesion (Staiger, 2006). A recent study conducted in our lab demonstrated 
that pure Mg was reabsorbed quickly during a 24hr exposure to normal human bronchial 
epithelium in vitro (Waterman, 2012). The inherently corrosive nature of Mg may be overcome 
via alloying elements. Preliminary data suggests resorbable magnesium-based materials can be 
utilized for the development of tracheal stents and thus, is an impetus for initiating the present 
study. Therefore, we hypothesize that exposure to MgZnCa alloy will not elicit 
inflammation or toxicity in normal human bronchial epithelial (NHBE) cells in vitro. We 
know that high purity mg corrodes rapidly, so most importantly we need to determine the 
interactions with the airway where the stent will be placed. Also, the effect of Mg alloys on 
NHBE cells is unknown. as a result, we want to know if Mg alloys will elicit an inflammatory or 
toxic response in NHBE cells.  
The objectives were to: 
1. Evaluate markers of cytotoxicity and functional genomics of inflammatory mediators 
following Mg alloy exposure. 
2. Evaluate mucus production, secretion and wire morphology following Mg alloy 
exposure. 
3. Evaluate wound healing and cell migration of NHBE cells exposed to Mg alloys in vitro. 
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CHAPTER 3 
Methodology 
3.1 Magnesium Samples 
 Magnesium zinc calcium alloy wires (0.5cm in length) were engineered in the National 
Science Foundation Engineering Research Center for Revolutionalizing Metallic Biomaterials 
(ERC-RMB) at North Carolina Agricultural and Technical State University. Pure magnesium (γ-
irradiated) samples were a kind gift of Dr. Gilbert (Vice President of Research & Development, 
ACell Inc.). 
3.2 Chemicals and Reagents 
Normal human bronchial epithelial (NHBE) cells, bronchial epithelial cell basal media 
(BEBM), SingleQuot supplement kits, DMEM and collagen were purchased from Mediatech 
(Manassas, VA). Acetic acid was purchased from Sigma Aldrich (St. Louis, Missouri). TGX 
gels, nitrocellulose membranes and Western blot reagents were acquired from Bio-Rad 
(Hercules, California). Lactate dehydrogenase kits were purchased from Roche (Indianapolis, 
Indiana). Anti-Phospho-IκB, anti-COX-2, and anti-iNOS and anti-rabbit IgG antibodies were 
purchased from Cell Signaling Technology (Beverly, Massachusetts). Anti-β-actin antibody was 
purchased from Santa Cruz Biotechnology (Santa Cruz, California). Enhanced 
chemiluminescence (ECL) kits for Western blotting were purchased from GE Healthcare Life 
Sciences Division (Fairfield, Connecticut). 
3.3 Cell Culture and Exposure 
 Primary normal human bronchial epithelial cells (NHBE) (CC-2540) were 
purchased mycoplasma free and source verified. NHBE cells were expanded for a period of 7-10 
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days in flasks until 70-80% confluency in high EGF BEBM expansion media containing 0.13 
mg/ml of bovine pituitary extract (BPE), 0.5 µg/ml of hydrocortisone, 12.5 ng/ml of recombinant 
human epithelial growth factor (rhEGF), 0.5 µg/ml of epinephrine, 10µg/ml of transferrin, 5 
µg/ml of insulin, 50nM of retinoic acid, 6.5 ng/ml of triiodothyronine, and 50 µg/ml of GA-
1000. Confluent cultures were then trypsinized, spun down, pelleted, and cryopreserved in the 
vapor phase of liquid nitrogen at a density of 1x10
6
. Since recent studies have shown that 
magnesium ions produced by the interaction of cells with magnesium materials have caused 
serious problems when using cellular metabolism based assays such as MTT and LDH, we used 
the air liquid interface which includes trans-wells. For initial seeding, trans-well inserts 
contained in six-well plates were coated with collagen solution consisting of 13µg of collagen 
per ml of acetic acid for 1hr. Plates were then washed with 1x phosphate buffered saline (PBS) 
for 10 minutes. After aspiration of PBS, adherent cells were seeded onto collagen coated trans-
well inserts and fed every two days for a period of 7 days with 2ml of bronchial epithelial cell 
basal  growth medium (BEBM) supplemented with 0.13 mg/ml of bovine pituitary extract 
(BPE), 0.5 µg/ml of hydrocortisone, 5 ng/ml of recombinant human epithelial growth factor 
(rhEGF), 0.5µg/ml of epinephrine, 10 µg/ml of transferrin, 5 µg/ml of insulin, 50nM of retinoic 
acid, 6.5 ng/ml of triiodothyronine, and 50 µg/ml of GA-1000. After 7 days, cells were taken to 
air liquid interface by aspirating media off the apical surface of the NHBE cell monolayer. Cells 
were then fed daily with 2ml of BEBM growth media for 14days and until mucus layer was 
present. Magnesium wires were manually placed on the apical surface of the cell/mucus 
monolayer for a time period of (0-48hrs). Microscopic observation was obtained 0hr, 4hr, 18hr, 
24hr, and 48hrs using an EVOS digital inverted light microscope (Advanced Microscopy Group, 
Bothell, Washington).  
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Figure 3 Schematic of the air liquid interface. An air liquid interface (A), displaying the 
transwell insert, apical compartment, microporous membrane (where cells rest) and basal 
compartment. (B) Fully differentiated NHBE cells exposed to the test material at the apical 
surface (Image developed by Dr. Thomas Gilbert). 
3.4 Lactate Dehydrogenase Assay (LDH)- Cytotoxicity Assay 
To determine the cytotoxic effect of magnesium wires on NHBE cell line, the lactate 
dehydrogenase assay was used by Roche. Lactate dehydrogenase (LDH) is a ubiquitous enzyme 
located in the cytoplasm of all mammalian cells. The release of this enzyme indicates a 
disruption of the plasma membrane thus a reduction in cell vitality. The spent media of NHBE 
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cells cultured in air-liquid interface was collected from the basal compartment after 24hr and 
48hr exposure to magnesium nanowires. The low and high controls as well as experimental wells 
were collected and then spun down to eliminate cell contamination. The supernatant was then 
placed in fresh 96 well plates and LDH was detected according to manufacturer’s instructions 
using a Molecular Devices VersaMax microplate (Sunnyvale, California) reader at 490 nm.  
3.5 Reverse Transcription Polymerase Chain Reaction (RT-PCR) 
 Total RNA was isolated using an RNeasy mini kit and an RNase-free DNase set 
(Qiagen, Valencia, CA). RNA (800ng) from each treatment group and control was reversed 
transcribed to produce cDNA using the iScript cDNA synthesis kit (Bio-Rad, Hercules, CA) 
according to manufacturer's instructions. Briefly, the total RNA (800ng) was combined with 5X 
iScript Reaction mix, nuclease-free water and iScript Reverse Transcriptase in a 25 l reaction.  
The samples were incubated in a iCycler thermal cycler (Bio-Rad) using the following reaction 
protocol: 5 minutes at 25
o
C, 30 minutes at 42
o
C, 5 minutes at 85
o
C and held at 4
o
C. The 
generated cDNA was then probed for pro-inflammatory mediators and antioxidants using the 
primers described in Table 1. produced from Invitrogen software. For the amplification of 
cDNA, GoTaq® Green Mastermix (Promega, Madison, WI) and protocol were used according to 
manufacturer’s instructions. For a 25ul reaction, 12.5µl of 2x GoTaq® Green Mastermix, 1µl of 
forward primer, 1µl of reverse primer, 4µl of template DNA, and 6.5µl of nuclease free water 
were combined and added to a RNase free and sterile PCR plate for each gene and sample. The 
samples were incubated in a preheated (95°C) iCycler thermal cycler (Bio-Rad) using the 
following reaction protocol: 4 minutes at 94
o
C; 35 cycles of 95
o
C for 30 seconds, 60
o
C for 30 
seconds, 72
o
C for 1 minute; and post-extension for 4 minutes at 72°C; and hold at 4
o
C. PCR 
products were resolved on  1% agarose gel in 1X Tris-Borate-EDTA buffer , pH 8.0 (Boston 
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Biologicals, Wellesley, MA) at 160 volts (V) and visualized using ethidium bromide.  All values 
were normalized to the constitutive expression of the housekeeping gene, β-actin. 
Table 1  
Primers Used in Polymerase Chain Reaction. 
Primers Oligonucleotide Sequence 5’ 3’ Tm (°C) Amplicon Length (bp) 
H_Bactin-Fwd ATGGATGATGATATCGCCGCG 57.5  
113 H_Bactin-Rev CTAGAAGCATTTGCGGTGGGAC 58.4 
H_NFκB-Fwd CACCTAGCTGCCAAAGAAGG 60.0  
657 H_NFκB-Rev GCCAATGAGATGTTGTCGTG 60.0 
H_NOS-2-Fwd ACAAGCCTACCCCTCCAGAT 60.0  
717 H_NOS-2-Rev TCCCGTCAGTTGGTAGGTTC 60.0 
H_GST-1-Fwd AGAAGGTGTGGCAGATTTGG 60.0  
645 H_GST-1-Rev CTTCAGCAGAGGGAAGTTGG 60.0 
H_SOD-2-Fwd GGAACGGGGACACTTACAAA 60.0  
750 H_SOD-2-Rev TCTTGCTGGGATCATTAGGG 60.0 
 
3.6 Western Blot Analysis 
Whole cell lysates were extracted from NHBE cells in control and magnesium wire 
exposed groups and quantitated using the Bradford assay. Equal amounts of protein were loaded 
in each lane with 4x sample loading buffer. Samples were boiled at 100 °C for 5 min before gel 
loading. Lysates (50µg) were then fractionated using 10% TGX gels (Bio-Rad) by sodium 
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dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) at 150 volts for 45 minutes. 
Fractionated proteins were transferred to nitrocellulose membranes using a semi-dry method at 
10V for 60 minutes. After blocking in 5% milk, nitrocellulose membranes were washed twice 
with tris-buffered saline-tween (TBS-T). Membranes were probed with primary antibody in 
5.0% bovine serum albumin solution (BSA) and gently rocked overnight at 4°C. Primary 
antibodies used were anti-human rabbit Phospho-IκB (Cell Signaling), anti-human rabbit, anti-
human rabbit SOD-1 (Cell Signaling), anti-human rabbit GST (Cell Signaling), anti-human 
rabbit iNOS (Cell Signaling) and goat β-actin (Santa Cruz) at a concentration of 1:1000.  Probed 
membranes were washed and secondary antibody anti-rabbit IgG (Cell Signaling) (1:2000) were 
used to detect primary antibodies. After washing, ECL detection reagents will be added (3ml) to 
probed membranes for one minute and subsequently imaged using Bio-Rad imaging technology; 
band densities will be analyzed using image lab (Bio-Rad).  
3.7 Mucin Enzyme Linked Immunosorbent Assay (ELISA) 
 To examine the effect of Mg and magnesium alloy wires on mucin production, an 
in-house enzyme linked immunosorbent (ELISA) assay was used. Magnesium and Mg alloy 
nanowires were placed in the cell/mucus monolayer for 24hrs. After exposure, NHBE cells were 
then rinsed with 500 µl of 1x PBS containing 100 µM dithiothreitol (DTT) followed by a second 
rinse of 500 µl of 1x PBS. Each rinse was collected and pooled for mucin ELISA analysis. β-
mercaptoethanol (12.5M/5µl) was added to each sample for a final concentration of 50mM and 
mixed well. Mucin samples were then centrifuged at 8,000rpm for 5 minutes. Dilutions of each 
sample (1:10, 1:30 and 1:50) were made in triplicate using 1x PBS, pH 7.4 and added to 96 well 
plate. Undiluted standards in duplicate were also added and incubated at room temperature for 
2hrs and then overnight at 4°C. After incubation, contents of each well were discarded and 
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washed twice with 1xPBS, pH 7.4. Blocking solution (200µl) containing 3% bovine serum 
albumin in 1x PBS, pH 7.4 was added to each well and incubated at room temperature for 2hrs. 
Wells were then washed twice with 1x PBS, pH 7.4. Primary antibody was diluted (1:1000/50µl) 
in 0.3% BSA/PBS, pH 7.4 was added to the entire 96-well plate and incubated at room 
temperature for 1hr. Subsequently, wells were washed three times with 1x PBS, pH 7.4 and 
probed with 50µl of secondary antibody, anti-human IgG-HRP linked (1:2000)(Santa Cruz) and 
incubated at room temperature for 1hr. Well contents were discarded and washed five times with 
PBS, pH 7.4. For detection, a 1:1 dilution of TMB substrate solution (KPL, catalog#50-76-02) 
and TMB peroxidase solution (KPL, catalog#50-65-02) were added to each well (50 µl) and 
incubated for 30 minutes. Following addition of 50 µl of stop solution (1M H2SO4), absorbance 
was read at 450 nm using a VersaMax microplate reader (Molecular Devices).  
3.8 Scanning Electron Microscopy (SEM) 
 After incubation with NHBE cells in air liquid interface for 24hrs or 48hrs, magnesium 
alloy wires were collected and examined by SEM to characterize the surface morphology of the 
recovered wires. A Hitachi SU8000 Field Emission Scanning Electron Microscope (SEM) was 
used to capture images on the micro- and nano-scale. Each sample was placed on a stage and 
attached using copper tape. Once the stage was prepared, it was inserted into the chamber which 
creates a vacuum seal before the specimen enters the microscope. During microscopic 
visualization, a low magnification setting was used to capture images of the specimen. Voltages 
from 1-20 kV were used to obtain the acceptable pictures of pure Mg and MgZnCa alloy wires. 
Brightness, contrast, and alignments were adjusted as needed.  
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3.9 Wound Healing Assay 
Cellular interaction and migration potential in response to magnesium alloy wires was 
evaluated by utilizing the wound repair method. After 21days, the NHBE cell monolayer, 
including mucus layer, will be cut 2-3 cm using a sterile blade. One magnesium alloy wire will 
be inserted into the wound for a period of 24hrs and 48hrs. Phase contrast microscopy images 
were taken at 0hr, 4hrs, 18hrs, 24hrs, and 48hrs with the EVOS microscope, to monitor the 
progression of wound healing and cellular migration. 
3.10 Statistical Analysis 
Statistical differences between the means were determined with a one-way analysis of 
variance (ANOVA) software and a treatment effect with P values less than 0.05 considered 
significant. All experiments were performed in triplicate and three biological replicates were 
completed. Results were expressed as means of + standard deviation of at least three biological 
experiments. Individual groups were compared with the unpaired Bonferroni post-test 
corrections.   
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CHAPTER 4 
Results 
4.1 Evaluation of the Expression of Inflammatory Mediators at the Gene and Protein levels 
and Cytotoxicity.  
The evaluation of gene modulation is a necessary assessment that gives insight of 
molecular changes induced by cellular interaction with biomaterial substrates. Genomic profiles 
of NHBE cells exposed to magnesium alloy wires for 24hrs were obtained for NFκB, iNOS, 
SOD and GST via a polymerase chain reaction. In Figure 4, there are no differences between the 
control (cells only) value and MgZnCa alloy expression of pro-inflammatory mediators; NFκB, 
fig. 4A and iNOS fig. 4B or antioxidants GST, fig.4C and SOD, fig. 4D. No inflammatory 
processes were up-regulated due to the presence of magnesium alloy biomaterials. 
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Figure 4 Gene expression of pro-inflammatory mediators and antioxidants. Quantitative 
polymerase chain reaction reveals no significant modulation (P value  > 0.05) of transcription 
factor NF-b(A), pro-inflammatory mediator iNOS (B) or antioxidants SOD (C), and GST (D), 
in NHBE cells after 24hr exposure to magnesium wires Data represents the mean + SEM, n=3. 
4.1.1 Modulation of Pro-inflammatory and antioxidant proteins in response to Mg 
Alloy Wire Exposure. Using the Western blot method to validate genomic profiles of NHBE 
cells exposed to magnesium alloy wire for 24hr, P-IκB-α (fig. 5A and fig. 6A), a regulator of 
NFκB, was found to have little to no expression in the presence of the MgZnCa alloy. The 
phosphorylation and degradation of IκB-α symbolizes the inactivation of the inhibitory complex 
composed of IκB-β and IκB-α. This complex prevents NFκB, which is normally sequestered in 
the cytoplasm, from entering into the nucleus and transcribing pro-inflammatory genes such as 
inducible nitric oxide or iNOS (fig. 5B and fig. 6B). We found that there was no appreciable 
phosphorylation of IκB-α suggesting that the presence of the magnesium alloy for 24hrs did not 
induce NF-κB-regulated oxidative stress compared to the unexposed cells. In similar studies, the 
generation of free radicals i.e., oxidative stress from the presence of metal alloys, were found to 
induce the phosphorylation of IκB encouraging the transcription of key pro-inflammatory 
proteins (Valko, 2006). Antioxidants superoxide dismutase, fig. 5C and fig. 6C, and glutathione-
s-transferase were not depleted in the presence of the MgZnCa alloy. 
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Figure 5 Expression of pro-inflammatory and antioxidant proteins. Immunoassay of 
phosphorylated inhibitor of kappa B alpha, P-IκBα (A), Inducible Nitric Oxide Synthase, iNOS 
(B), Glutathione-S-Transferase, GST (C), and Superoxide Dismutase, SOD (D), revealed that 
there was no detectable inflammation caused by a 24hr exposure to wires of Mg or Mg alloy. 
Beta-actin (E), expression was used as loading control. Bands show are representative of six 
blots. 
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Figure 6 Protein expression of pro-inflammatory mediators and antioxidants. Densitometric 
analysis of P-IκBα (A), iNOS (B), GST (C), and SOD (D), protein expression in NHBE cells 
after 24hr exposure to Mg wires shown in figure 5. There was a significant difference in the 
expression of P-IκBα between the Pure Mg and our Mg alloy (P value < 0.05). No differences between 
iNOS, GST and SOD protein expression levels as determined by one-way analysis of variance 
(ANOVA) (P value > 0.05). Data represents the mean + SEM, n=6. 
 
 4.1.2 Cytotoxicity. In recent studies, magnesium ions produced by the interaction of cells 
with magnesium materials have caused serious problems when using cellular metabolism based 
assays such as MTT and LDH; false negatives or positives and interference with dye stability 
have been an issue when analyzing the biocompatibility of metal alloys in vitro (Witte, 2008).  In 
these studies the magnesium metal came in direct contact with the media that was in turn tested 
for cytotoxicity. However, within this study, our experimental design, which employs use of the 
unique air liquid interface cell culture model, provides layers of separation between wires and 
cell culture media and prevented Mg ion interference; the media collected for the LDH 
measurement was collected from the basal compartment (see figure 3).  The activity of LDH was 
monitored at 24hr and 48hrs for control and Mg alloy wires exposed NHBE cells. Magnesium 
wire only controls were also incorporated. Fig.7 shows at our time points of interest (24hrs and 
48hrs) there was little to no cytotoxicity. It should be noted that fully differentiated NHBE cells 
demonstrate high levels of lactate dehydrogenase release, thus levels in control cells are normally 
high. We feel that the presence of the high purity Mg and Mg alloy wires aide in cell viability.  
At the time points of interest, the LDH levels decrease with Exposure to Mg and Mg alloy wires.  
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Figure 7 Lactate dehydrogenase evaluation. Lactate dehydrogenase assessment to determine 
plasma membrane damage of NHBE cells in air-liquid interface exposed to magnesium wires for 
24hr and 48hr. Data are presented as mean ± SEM; n=3. 
4.2 Evaluation of Mucin Production and Secretion following Mg Alloy Exposure in vitro. 
 Mucus lubricates the airways and helps in the removal of foreign particles that might 
have been inhaled, such as dust or bacteria (Ji, 1999). The airways are normally cleared of excess 
mucus and foreign particles by a combination of coughing and mucociliary clearance, which is 
the coordinated movement of tiny hairs (cilia) that project into the mucus-lined airways (Kumar, 
2010).  Additional mucus is produced during infection or when there is airway irritation, from 
smoke or dust, for example (Reed, 2001). Hypersecretion from hyperplastic goblet cells causes 
airway mucous plugging, especially in peripheral airways, where large, numerous secreting 
goblet cells can more easily cause obstruction (Reed, 2001).  An enzyme linked immunosorbent 
assay (ELISA) was utilized to determine if magnesium and magnesium alloy wires inhibited or 
increased mucin production in NHBE cells. At 24hrs, a slight reduction in magnesium alloy 
wires- mediated mucin production was found in relationship to the control (Figure 8). Mucin 
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production and cell migration were unaffected due to magnesium alloy interaction suggesting that cell 
cycle progression, cell growth and functionality were maintained.  
 
Figure 8 Airways mucus secretion assessment. In vitro evaluation of global mucin production in 
NHBE cells, where mucin was collected following 24 hr exposure to Mg wires. Wires of Mg 
caused more mucin secretion than wires of a novel MgZnCa alloy in fully differentiated human 
airway epithelial cells in vitro (p value = 0.0253) as determined by a Pan-Mucin ELISA. Data are 
presented as mean ± SEM, n=9.  
4.2.1 Evaluation of cell migration of cells exposed to MgZnCa alloys and evaluate 
wire morphology following exposure to MgZnCa alloys in vitro. It is known that Mg is prone 
to degrade rapidly at physiological pH (7.4); therefore, it is important to monitor the degradation 
the Mg alloy wires underwent after 24hrs of exposure to mucus-secreting cultures of NHBE 
cells. The evaluations shown in figure 9 shows that there was minimal degradation of the 
MgZnCa alloy (D-F) in comparison to pure Mg wires (A-C) which underwent mass degradation. 
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Figure 9 Scanning Electron Microscopy images of Mg and MgZnCa alloy wires. SEM imaging 
of wires of Mg and MgZnCa (A, D) before and (B, E) after 24hr exposure to NHBE cells in 
vitro.  Cross-sections of (C) Mg and (F) MgZnCa post-exposure revealed concentric layers 
consisting of a mucus-based capsule (arrow) surrounding corrosion product (double arrows) atop 
the metal core (arrow head). 
 4.3.2 Wound repair.  The wound repair assay has been used to evaluate the potential of 
various agents to close manually or chemically induced wounds for many years. It is well 
established that magnesium is a cofactor in many processes within the body. To determine the 
impact of magnesium alloys on wound repair, magnesium alloy wires were placed in a NHBE 
cell monolayer wound for 24hr and 48hrs. The progress of wound healing is depicted in Figure 
10 was recorded at 0hr prior to injury, fig. 10A, 4hrs after injury (fig. 10B (pure Mg) and fig. 
10F (MgZnCa alloy)), 18hrs post injury (fig. 10C, pure Mg and fig. 10G, MgZnCa alloy), 24hrs 
post injury (fig. 10D, pure Mg and fig. 10H, MgZnCa alloy) and 48hrs post injury (fig. 10E, pure 
Mg and fig. 10I, MgZnCa alloy). Cell migration and wound closure can be noted. 
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Figure 10 Wound closure in NHBE monolayer cultured with Mg-based wires. EVOS 
micrographs of fully differentiated NHBE monolayer prior to injury (A) and Mg (B-E) and 
MgZnCa (F-I) wire exposure at 4hr (B,F), 18hr (C,G), 24hr (D,H) and  48hr (E,I) time points. 
Note cell migration and wound closure (arrow). Data represents the mean + SEM, n=6. 
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CHAPTER 5 
Discussion 
 Treating tracheobronchial disorders caused by malignant or benign tumors, extrinsic 
compression, post-intubation tracheal injuries, tracheomalacia or sequelae caused after 
tracheostomy is a complex issue requiring a multifaceted solution. Common treatments range 
from balloon dilations to conventional surgical treatments and even highly invasive surgical 
procedures. Interventional pulmonology otherwise known as airway stenting has developed in 
the field of pulmonary medicine focused on using bronchoscopic techniques to treat airway 
disorders (Saito, 2005). Stents can be classified into silicone (or synthetic rubber) tube stents or 
metallic stents. Silicone stents are relatively inexpensive and easily molded to various degrees of 
firmness and flexibility. They have good tolerance and can be removed easily even after years of 
placement. Their major disadvantage is that the frequently migrate causing reocclusion. Metallic 
stents are slowly gaining popularity because of their ease of insertion and have greater radial 
force, flexibility and dynamic expansiveness (Rafanan, 2000). There is less frequent migration 
with metal stents because they are typically incorporated in the bronchial mucosa making them 
permanent. Metallic stents have been associated with formation of granulation tissue, fistula 
development and difficult recovery (Saito, 2005). The disadvantages of metallic stents are 
outweighed by their benefits.  To alleviate many of these obstacles, the optimization of the stent 
material has been implemented.  
In this study we evaluated the biocompatibility of magnesium alloy wires with fully 
differentiated airway epithelial cells in vitro. To date, there have been few studies evaluating the 
efficacy of magnesium alloys as a core material for tracheal stenting. It was determined that there 
was no appreciable modulatory effect on key pro-inflammatory genes and proteins of the NF-κB 
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signaling pathway. Cytotoxicity analysis of MgZnCa exposed cells yielded results correlating 
with genomic and proteomic analyses in that lactate dehydrogenase activity levels were not 
elevated after 24hr and 48hr. Mucin production and cell migration were unaffected due to 
magnesium alloy interaction suggesting that cell cycle progression, cell growth and functionality 
were maintained. Magnesium has been used in orthopedic implants and cardiovascular stenting 
(Purnama, 2010), and thus has high biocompatibility. However, to date, there has been little to no 
studies that evaluate the efficacy of using Mg based alloys as a foundation material for tracheal 
stenting. In this current study, a novel MgZnCa alloy showed promise as a candidate for primary 
use in tracheal stent scaffolding using an in vitro air liquid interface culture model. 
The generation of metal ions from degraded metal biomaterials has been thought to 
promote oxidative stress (Purnama, 2010). When the production of reactive oxygen species 
(ROS) is increased or the scavenging mechanisms are ineffective, the result is an excess of these 
free radicals, leading to oxidative stress (Kumar, 2010). Oxidative stress can activate important 
pro-inflammatory transcription factors, mainly NF-κB. In similar studies oxidative stress arising 
from the presence of metal alloys, was found to induce the phosphorylation of IκB that 
ultimately encouraged the transcription of key pro-inflammatory proteins (Valko, 2006). 
Genomic and proteomic evaluation of NHBE cells, in this study, exposed to the novel MgZnCa 
alloy showed no significant modulation of NF-κB (or P-IκB in proteomic analysis). This is 
consistent with preliminary studies with pure Mg samples (Waterman, 2012). Since NF-κB 
complex remained sequestered in the cytoplasm, pro-inflammatory genes like iNOS was not 
transcribed and did not show significant modulation in this study. Antioxidants tested in this 
study, superoxide dismutase (SOD) and glutathione-S-transferase, also confirm the absence of 
oxidative stress as they were not depleted in the presence of the novel MgZnCa alloy. One study 
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used to assess the possible mechanism of  action of chromium (VI) and arsenic (III) ions, found 
that NF-κB activation was inhibited through the interference of inhibitory molecule, IKK and 
NF-κB DNA binding or from impeding the activity of cAMP-responsive element binding 
protein or (CREB) (Kippler, 2012). Since NF-κB is also responsible for cell growth, cell cycle 
progression, and neoplastic transformation (Chen, 2002), we know that the presence of 
magnesium ions did not inhibit the transcriptional activity of  NF-κB, because of the elevated 
level of cell migration seen in the wound repair assays. 
 The occurrence of cytotoxicity in relationship to cell/alloy interaction can be caused by 
many factors. One main factor is the influx of metal ions from the degradation of implanted 
biomaterials. Increases in systemic levels of metal alloying ions such as manganese have been 
found to induce neurotoxicity (Crossgrove, 2004) and zirconium ions have been found to be 
associated with liver, lung, breast and nasopharyngeal cancers (Song, 2007).  In this study, it was 
determined that our MgZnCa alloy caused negligible stimulatory or deleterious effects on 
differentiated cultures of NHBE cells in vitro.  
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CHAPTER 6                                                                                                                                                 
Conclusion and Future Directions 
As the journey toward developing a reliable biodegradable stent progresses, we know that 
there are many challenges that lie ahead. Overcoming problems with traditional stents is key to 
developing the ideal stent. Zakaluzny described the ideal stent as; (1) one that is easy to insert 
and remove, (2) has expansion force adequate to maintain airway patency against compressive 
without causing pressure to the mucosa that could damage the airway, (3) that is available in 
different sizes to accommodate various airway sizes and obstructions, (4) one that maintains its 
placement in the airway without migration, (5) is made of material that does not irritate the 
airway, (6) does not obstruct the airway tributaries and (7) does not inhibit mucociliary action 
(Zakaluzny, 2003). Unfortunately there is not a stent that maintains all of these qualities, 
however, this study provides progressive step towards creating the ideal airway stent. 
In the present study, using an air liquid interface model, fully differentiated NHBE cells 
were exposed to a novel MgZnCa alloy and was shown to perform as well as, and at times, better 
than, high purity Mg. We have determined via functional genomic analysis that the novel 
MgZnCa alloy had no modulatory effect on pro-inflammatory transcription factor NF-κB or pro-
inflammatory mediatory iNOS. There was no degree of difference in the expression of P-IκBα or 
iNOS proteins exhibited in our western blot analysis, subsequently validating our genomic 
evaluation. Antioxidants SOD and GST were not depleted in the presence of the MgZnCa alloy 
via genomic and proteomic confirmation. Airway cell migration and wound closure was 
enhanced in the presence of the novel MgZnCa alloy as confirmed by the wound repair assay. 
Cytotoxicity analysis also correlated with genomic and proteomic evaluations in that no 
appreciable increases in LDH release were found after exposure to novel MgZnCa wires for 
43 
 
24hrs and 48hrs. Based on SEM images, we are able to determine that MgZnCa alloys 
underwent less degradation and made for a more resilient alternative material compared to pure 
Mg. in addition, we are able to conclude that due to less degradation of the novel MgZnCa wires 
there was less mucin secretion compared to pure Mg confirmed via a mucin ELISA.  
An obvious limitation in the present study is that a ‘static’ culture system where culture 
media was changed either a few times or once daily was utilized.  An ideal in vitro system would 
by dynamic where media and air are continuously circulated to simulate respiration and blood 
flow, such as seen with bioreactor technologies.  Currently, efforts are underway to develop a 
suitable bioreactor to maintain and investigate the cellular responses in the airway.  Even with its 
obvious limitations, the ALI cell culture model used here is the current state-of-the-art for 
evaluating in vitro responses of differentiated tracheobronchial epithelial cell cultures because 
cells grown in this manner are essentially identical in anatomy and physiology to the same cells 
within the body (personal communication with Dr. Jenora Waterman) and thus, is reliable for 
understanding potential effects in vivo. 
Future studies may include the incorporation of biofunctional coatings alone or together 
with pharmaceuticals (e.g., antibiotics) with Mg alloy stent materials and evaluation of 
cytocompatibility. Given that metal stents can cause granulation tissue and granulation tissue can 
become a culture medium for bacteria. Cultures of granulation tissue have shown to grow 
numerous bacteria such as Streptococcus viridians, Pseudomonas aeruginosa, nonhemolytic 
streptococci and Staphylococcus aureus (Zakaluzny, 2003). Silver has been used for thousands 
of years as a precious metal by humans in different applications and the antimicrobial activity of 
silver appears significantly high. It is more toxic to microorganisms than any other metal 
(Ansari, 2011). Preliminary studies in our lab suggest that silver may provide antimicrobial 
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properties through inhibition of bacterial that dominate the airways of asthmatics (unpublished 
studies). 
In conclusion, the work presented here support the efficacy of using the novel MgZnCa 
alloy in the development and manufacture of tracheal stents. 
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Appendix A 
Protocols 
Protocol #1: RNA Extraction 
Qiagen RNA extraction kit was used 
Before starting 
1. Ensure that 10 l β-ME/1ml Buffer RTL has been added. 
2. Ensure that ethanol has been added to Buffer RPE (before initial use). 
3. If performing on column DNase digestion protocol, prepare DNase I stock solution. 
[10 l DNase I Stock + 70 l Buffer RDD = 80 l/rxn] 
4. During procedure, work quickly (at RT). 
 
For animal cells grown in a monolayer (do not use more than 1 x 10
7
cells). Cells grown in a 
culture dish may be lysed directly, but cells grown in a flask must be trypsinized and collected in 
a microfuge tube. 
 
To Lyse Cells 
1. Aspirate media. 
2. Add Buffer RTL Dish diameter <6 cm2 (12-well dish) = 350 l; 6-10 cm2 (6-well 
dish)= 600 l 
3. Collect cell lysate with a cell scrapper (rubber policeman).  
4. Pipet lysate into a microfuge tube and vortex to remove clumps. 
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5. Homogenize cells by passing lysate at least 5 times through a 20-gauge (0.9 mm 
diameter) fitted RNase-free syringe (alternatively add lysate to a QIAshredder spin 
column fitted with a 2 ml collection tube and spin a max speed for 2 min). 
6. Add 1 volume (usually 350 or 600 l) of 70 % EtOH to the homogenized lysate and mix 
by pipetting.  
7. Add up to 700 l of the sample (including any ppt.) to RNeasy spin column fitted with a 
2 ml collection tube. Close tube gently. 
8. Spin for 15 sec at ≥8000g (≥10,000 rpm) to wash column. Discard flow-through and 
collection tube. 
 
On-Column DNase I Digestion 
D1. Add 350 l RW1 to the column and spin 15 sec at ≥8000g (≥10,000 rpm) to wash 
column.  
D2. Add 80 l DNase mix to the center of each silica-gel membrane. Incubate at RT for 
15 min. 
D3. Add 350 l RW1 to the column and spin 15 sec at ≥8000g (≥10,000 rpm) to wash 
column.   
 
Wash and RNA Elution 
9. Add 500 l Buffer RPE onto column. Close gently. 
10. Spin for 15 sec at ≥8000g (≥10,000 rpm) to wash column. Discard flow-through. 
11. Add another 500 l Buffer RPE onto column. Close gently. Spin for 15 sec at ≥8000g 
(≥10,000 rpm).  
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12. To dry column, spin at max speed for 1 min. 
13. To elute, transfer column to a 1.5 ml microfuge tube and add 50 l RNase-free water 
directly to the silica-gel membrane. Close gently. 
14. Spin for 1 min at ≥8000g (≥10,000 rpm). 
 
Determine RNA concentration and purity 
1. Dilute RNA 1/50 (1 l sample + 49 l water). 
2. Measure A260. 
 A260 = 1  40 g RNA/ml 
 [RNA Sample] = 40 g /ml x A260 x dilution factor  
Store RNA at -70
o
C or proceed with cDNA synthesis. 
 
iScript
TM
 cDNA Synthesis Kit (BIO-RAD) 
Component      Volume per reaction 
5x iScript Reaction Mix     4 l 
iScript Reverse Transcriptase    1 l 
Nuclease-free water     x l 
RNA template* (100 fg to 1 g Total RNA)  x l 
Total Volume             20 l 
 
 
Reaction Protocol 
Incubate complete reaction mix: 
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Step 1  5 min @ 25
o
C 
Step 2  30 min @ 42
o
C 
Step 3  5 min @ 85
o
C 
Step 4  Hold @ 4
o
C (optional) 
 
*When using larger amounts of input RNA (> 1g) the reaction should be scaled up, e.g. 40 l 
for 2 g, 100 l for 5 g to ensure optimum synthesis efficiency. 
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Protocol #2: RNA Quantification 
(NanoDrop 2000 Spectrophotometer) 
1) Open the NanoDrop application on the laboratory computer 
2) Select the nucleic acid protocol 
a) Change the units to ng/ µL 
b) Change from DNA to RNA 
3) Clean the NanoDrop with ethanol 
a) Clean the NanoDrop between each sample as well 
4) Use nuclease free water to blank the NanoDrop 
a) Pipette 1uL of nuclease free water directly onto the center of the NanoDrop sensor 
b) Close the top of the NanoDrop and click blank 
5) Use the RNA concentration data sheet to record your values 
a) Clean the sensor with ethanol 
b) Place 1uL of RNA on the sensor  
c) Close the lid and click “measure” 
d) Repeat for all of your samples 
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Protocol #3: Reverse Transcriptase PCR 
iScript Reverse Transcriptase kit was used 
In the RNA hood: 
1) Turn on the U.V. light for at least 15 minutes to sterilize all surfaces 
a) wipe all surfaces with ethanol and RNase zap 
2) Using the sterile RNA hood, pipette the pre-calculated amount of 5x iScript mix, 1x RT 
(from kit), nuclease free water. 
i) To calculate the amount of RNA needed from each sample, you’ll need to divide 500 
by the concentration  
(1) 500÷ RNA Concentration= µL of RNA sample needed 
ii) Each sample should have 20 µL total 
(1) The combined total of nuclease free water and RNA sample is 15. 
(a) The amount of nuclease free water is determined by the amount of RNA 
sample minus 15. 
(i) RNA sample - 15= µL of nuclease free water 
(2) You’ll add 4 µL of 5x iScript to each reaction  
(3) You’ll add 1 µL of 1x iScript RT to each reaction  
(4) E.g.  
Sample  # RNA µL Water (µL) 5x iScript (µL) 1x iScript (µL) 
1 5.0 10.0 4.0 1.0 
2 3.0 12.0 4.0 1.0 
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3) Place each tube into the iCycler PCR machine and run cDNA program found under 
waterman protocols 
4) Remove at the end of the cycle and store in freezer @-20˚C. 
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Protocol #4: Polymerase Chain Reaction 
 
 
1) Create a Mastermix for each primer using the following template: 
a) Creates only one reaction 
i) Multiply each value by the number of reactions you need 
b) Place cDNA in PCR tube, then add 23 μL of “mastermix” 
cDNA Template 2μL  
FWD-Primer 0.5 μL 
REV-Primer 0.5 μL 
2x GoTaq Green 12.5 μL 
Total 25 μL 
2) Add 23 μL of mastermix to each pre-labeled tube with 2 μL of cDNA template and in the no 
template tube. 
3) Quickly pulse all tubes in shaker to pull all components down. 
4) Using iCycler place all tubes in appropriate slots and be sure that all lids are secure and 
closed. 
5) Log into iCycler and go to:  
a) Protocols 
b) Waterman 
c) Oxstress program 
d) Click “run” 
i) Change sample volume on run screen to 25 μL 
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e) Begin run 
6) At the end of the cycle press end hold on iCycler and to store freeze samples in -20˚C 
freezer. 
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Protocol #5: Agarose Gel  
 
1) Weigh 1.0 gram of agarose on a weigh boat 
2) Add 100 ml of TBS buffer in a flask (250ml) and add agarose 
3) Microwave on high until there are bubbles (right before boiling) present  
a) Periodically stop the microwave and swirl solution noting the clarity each time (maybe 
two times) 
b) Continue to microwave until the solution is totally clear 
4) Let the flask cool slightly ( about 30 sec. to a minute) 
5) Add agarose solution to gel casting site 
6) Add 7 µL of marker (depending on which type of marker you choose to use) to lane 1 of your 
solidified gel  
a) Add marker in-between each set of samples you plan to run 
7)  Pipette 15 µL of sample in each well. 
a) If you’ve used the 51 well comb, place 10 µL of sample in each well 
8) Start the gel at 80 volts to get the DNA out of the wells 
a) You may turn the voltage up to 120 volts for the remainder of the run 
9) When the gel has run ¾ of the way down the gel stop it the run 
10) Stain the gel with Ethidium Bromide for 15-20 minutes 
a) **Beware Ethidium Bromide is a carcinogen, use extreme caution with each use** 
11) Image the gel following Ethidium Bromide staining  
a) Refer to protocol 6 for imaging 
12) Clean all surfaces and dispose of gel in Ethidium Bromide gel biohazard waste. 
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Protocol #6: Bio-Rad Image Lab Gel Imaging Protocol  
The Bio-Rad imager is designed to be on all the time. If the Imager is not on, the ON/OFF switch 
is located on the front of the imager in the right bottom corner.  
1. Pullout the UV drawer located on the front of the imager. 
2. Place your stained gel directly on the UV table and close the drawer.  
a. If you are imaging a protein blot, place the white light cover directly 
on top of the UV light table. 
b. Place the blot directly on the white light cover and close the drawer. 
3. Open the “Image Lab” program on the laboratory computer located next to the 
imager. 
4. When the “Start Page” dialogue box appears select new protocol. 
a. If the “Start Page” dialogue box does not automatically pop-up go to 
the tool bar and select “New Protocol” (it looks like a sheet of clean 
printer paper) 
5. Select a single channel protocol 
a. Skip the imaging area section 
b. Select automatic or enter a manual exposure time 
6. Select position gel (yellow box on the lower left-hand corner) 
a. Use the zoom function to resize the imaging box around your gel or 
blot. 
7. Select Run Protocol 
a. Your image will be captured at this time 
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8. After the image has been saved, please remove the gel and clean the UV table 
with 70% Ethanol. 
To perform densitometry on the bands: 
9. Click the Lane and bands icon located in the left hand column named 
“Analysis Tool Box” 
a. For best results manually input the number of lanes that you will be 
detecting bands. 
i. You may use the automatic option, however there is a large 
chance that it may not detect all lanes. 
10. Select the bands tab and click detect bands 
a.  When the “band detection” dialogue box appears, select your 
preference in band detection sensitivity. 
i. Depending on your bands you may need to increase or decrease 
the detection sensitivity.  
b. Choose detect 
i. If all of your bands were not detected simply add them by 
clicking “add” and clicking on the band that was omitted. 
ii. If by chance there is a band detected and it is not a band you 
wish to analyze simply delete it by selecting “delete” and 
clicking on the unwanted band. 
11. Located in the main tool bar select “Analysis Table” 
a. You will be able to see all relevant information for each lane and band 
detected. 
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b. You may export these files to Microsoft Excel 
12. To save simply select “File” and “Save As” 
i. Select the appropriate destination and save the file.  
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Protocol #7: Preparing Mammalian Whole Cell Extracts 
1) Place cells on ice. Labeled microfuge tubes and place on ice. 
2)  Removed media from cells by vacuum-aspirating and washed gently with 1 ml cold PBS 
containing Phosphatase Inhibitor (1 ml aliquots at -20°C) 
3)  While on ice, add 100-200 µl ice-cold “Extraction Buffer” to each well (6 well plate) 
a) To make Extraction Buffer: 
i)  Make 1X Cell Signaling Lysis Buffer 
(1) Obtain 10X CS LB Stock (500 aliquots at -20°C) dilute with 4.5ml-deionized 
water. 
ii) Add 870 µl 1X CS Lysis Buffer prepared from (i) to 100 µl 10X Roche® Complete 
Protease Inhibitor Cocktail Tablet aliquots (100 µl aliquots stored at -20°C, labeled 
“PIT”). 
iii) Add 970 µl Pre-Extraction Buffer(ii.) to: 
(1) 10 µl Phosphatase inhibitor Cocktail 1(20 µl stored at 4°C) 
(2) 2. 10µl protease inhibitor cocktail 1(20 µl stored at -20°C) 
4) Rock plates on ice and work one plate at a time. 
5)  Use a cell scraper to scrape wells to one side of the well. 
6) Transfer this lysate to the adjacent well. (Clean cell scraper in between samples with 70% 
ethanol and wipe with a Kimwipe) 
7)  Transfer lysate to appropriate tube and return to ice 
8) Sonicate 3 times for 7 second bursts with 1 minute incubations on ice 
9)  Pellet debris at 15,000 rpm at 4°C for 15 minutes 
10) Transfer supernatant to a clean tube. 
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11) Determine protein concentration via Bradford Assay 
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Protocol #8: Microplate Bradford Assay 
1) Use two (2) sets of BSA standards (800, 400, 200, 100, 50, 0 mg/ml) stored at 4oC. 
2) Dilute the Bradford Reagent Assay Dye (stored at 4oC) 1:4 in dH20. 
3) Prepare a 1:100, 1:200 and 1:300 dilution of each unknown sample in triplicate. 
4) Add 10 μL BSA standards, 10 μL unknown sample dilutions (in triplicate). 
5) Add 190 μL diluted Bradford Assay Dye to each sample well. 
6) Read plate using plate reader. 
a) Turn on VersaMax Microplate Reader and put plate in drawer. Press “Drawer” button to 
open/close drawer. 
b) Click “SoftMax Pro v5” icon. 
c) Go to “Protocols” drop-down menu. 
d) Go to “Protein Quant.” 
e) Go to “Bradford.” 
f) Click “Template” to enter plate/sample information (i.e., Standard ID, Unknown Sample 
ID…). 
g) Click “Read.” 
h) When finished, save and print results & standard curve 
i) MAKE SURE DRAWER IS CLOSED & COVER INSTRUMENT. 
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Protocol 9: Western Blot 
SDS-PAGE Analysis 
1. Added sample buffer to each extract (1/4 volume of 4X or ½ of 2X Laemmli Sample 
Buffer). Generally used 30-60 µg/ lane of cell extract for mini gels. 
2. Boiled samples for 5 minutes. 
3. Loaded samples onto SDS-PAGE gel. 
4. Ran gel at 115 volts for 1 hour & 20 minutes at RT. (Run gels according to 
manufacturer’s instructions). 
Semi-Dry Transfer 
1. Soaked 2 pieces of extra thick filter paper and one piece of nitrocellulose in Western 
transfer Buffer. 
2. Made a sandwich (bottom to top) with 1 piece of filter paper, nitrocellulose, gel and 1 
piece of filter paper. Place in semi-dry transfer apparatus and run at 10 V for 30-60 
minutes. 
Wet  Tank Transfer 
1. Presoaked 2 pieces of extra thick filter paper and one piece of nitrocellulose in ice cold 
transfer buffer. 
2. Made sandwich with 1 filter pad, 1 piece of filter paper, nitrocellulose, gel, 1 piece of 
filter paper, 1 filter pad. Load into cassette and then into tank. Distribute ice around tank 
to keep temperature cool. Run gel at 100 V for 60 min. 
 
Blocking 
1. Nitrocellulose was removed from sandwich. 
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2. Blot was placed in 5% milk blocking solution and rocked at room temperature for one 
hour. 
3. Blot was washed with TBS-T for 15 minutes with gentle agitation and washed twice for 5 
minutes with gentle agitation. 
Primary Antibody 
1. Diluted appropriate antibody in TBS-T plus 0.5% BSA. Generally used 1:1000 (i.e. 10 µl 
antibody in 10 ml TBS-T/albumin). 
2. Incubate blot overnight at 4ºC with agitation. 
3. Blot was rinsed the following morning with TBS-T for 15 minutes once and washed 
twice for 5 minutes with TBS-T. 
Secondary Antibody 
1. Diluted secondary antibody in TBS-T plus 0.5% BSA. Generally used 5µl in 10 ml. 
2. Incubated blot for one hour with agitation at room temperature. 
3. Blot was washed with TBS-T for 15 minutes with gentle agitation and washed twice for 5 
minutes with gentle agitation. 
ECL Detection 
1. Mixed equal amounts of ECL detection reagents (1-2 ml each per blot). It should come to 
room temperature before use. 
2. Pipetted reagent over entire surface of membrane. Incubated for one minute. 
3. Wicked excess liquid off by using dry edge of kimwipe. 
4. Membrane was placed in sheet protector. 
5. Exposed film to membrane. Exposure times vary depending on antibody and protein 
source. 
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Automated Film Development 
1. Made developer and fixer. After use wrap container in foil. 
a. Developer 
i. 800 ml warm tap water 
ii. 200 ml developer 
iii. Pour into flask and swirl 
b. Fixer 
i. 720 ml warm tap water (16ºC to 27ºC ) 
ii. 250 ml rapid fixer (solution A) 
iii. 30 ml hardener (solution B) 
iv. Pour into flask and swirl 
 
2. After exposure, film was run through Hope Autovisualizer Processor. 
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Protocol #10: Growing NHBE Cells 
(Modified protocol of Dr. Kimberly L. Raiford) 
 
NOTE: Always use sterile technique while performing tissue culture procedures. Refer to 
“SOP for Sterile Technique and Tissue Culture Equipment” document for details. 
 
Day 1: Seeding Cells 
1. Select plate type 6-well (plastic only/transwell insert-for going to air). 
2. Label plate(s) with Name, Date, Plate # and donor (e.g. 3T0025). 
3. Make collagen solution to coat wells by diluting collagen stock in 0.02 N Glacial 
Acetic Acid. 
a. Collagen Stock Solution: 3.13 mg/ml  3.13 g/l 
b. Desired final concentration = 50 g/ml 
c. 50/3.13 = 15.97 use 16l collagen stock/1 ml acetic acid. 
4. Add 0.5 ml/well and swirl plate to achieve complete well coverage. 
5. Let stand at RT for 1 hour. 
6. Vacuum-aspirate excess collagen solution and wash wells with 1 ml PBS for 10 min 
at RT. 
7. Remove PBS and add 2 ml of conditioning media (50:50 without additives). 
a. Preparing 50:50 Media (viable for 6 weeks @ 4oC) 
i. Obtain a T-75 tissue culture flask (#3275) 
ii. Obtain BEBM & DMEM and mark fluid level in BEBM bottle 
iii. Pour 250 ml of BEBM into flask and 250 ml of DMEM into BEBM 
bottle. 
iv. Add 250 ml of BEBM from flask to DMEM bottle. 
v. Label accordingly with 50:50, initials, date and refrigerate. 
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8. Add 2 ml of conditioning media to wells and incubate @ 37oC/5% CO2 for 1 hour. 
9. Add “2 ml/well” in 50 ml tube and “1 ml/well” in a 50 ml tube (to reconstitute cells 
for distributing into wells) and warm both tubes in 37
o
C water bath for 15-30 min. 
a. Preparing Complete Media (viable for 6 weeks @ 4oC) 
i. Get a “Clonetics BEGM Singlequots” pack (-20oC freezer in plastic 
bag). 
ii. Remove BPE & Retinoic Acid from Singlequots pack and place in 
“Extras” container in -20oC freezer. 
iii. Get Nystatin & BSA from -20oC freezer and BPE & Retinoic Acid 
(light sensitive, use small tubes) from the -70
o
C. 
iv. Thaw components at RT. 
v. Add all (11) components to 50:50 bottle, check them off on label from 
Singlequots pack and affix label to bottle, date, initial & refrigerate. 
10. Determine how many vials of cells you will need (2.0 x 106 NHBE cells/vial) to seed 
the plates. Generally use ~ 1 x 10
4
 cells/well (e.g., 3 6-well plates  18 wells = 
13,888.88 cells/well). Record seed concentration. 
a. Cells are kept in liquid nitrogen tank. 
b. Remember to mark log when you take cells! (Box 5A) 
i. When retrieving LN2-frozen cells get an ice bucket with lid. Tubes 
have been known to burst. 
ii. In hood, partially unscrew cap to make sure no LN2 is in the threads of 
the vial. The close tightly again. 
iii.  Quickly thaw cells for 1 min in 37oC water bath. 
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iv. Add cells to pre-warmed tube with “1 ml/well” volume. Pipet twice 
(gently) to mix. 
11.  Vacuum-aspirate conditioning media. 
12. Add 2ml complete media to wells (use “2ml/well tube) first then add 1 ml cells to 
each well (or transwell chamber if “Going to Air”).  
13. Gently swirl plates to get even coverage of the wells. Incubate at 37oC/5% CO2 ON. 
 
Day 2: Feeding Cells 
1. Pre-warm (37oC water bath) 3 ml/well complete media for 15-30 minutes. 
2. Vacuum-aspirate spent media. 
3. Add 3 ml of media to each well (OR 2 ml to bottom + 1 ml transwell chamber if 
“Going to Air”). 
4. Gently swirl plates and place back in incubator. 
5. Wait two days before feeding cells again. Then feed them daily/every other day until 
they reach 80-95% confluency (around ~Day 5-7 depending on initial seed 
concentration). 
6. Proceed with experiments OR proceed to “Going to Air” protocol. 
 
Day 7: Going to Air 
1. Vacuum-aspirate media. 
2. Add 2 ml pre-warmed media to the bottom of well only. Gently swirl plates and 
return to incubator. 
3. Cells must be fed every day at this point. 
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50:50 Media with Additives  Complete Media Components 
Additive 
Stock Conc. 
(M/H) Volume* Final Conc. 
Nystatin (in-house, -20
o
C) 22,000 U/ml 0.5 ml 22 U/ml 
BSA (in-house, -20
o
C) 1.5 mg/ml 0.5 ml 1.5 g/ml 
Gentimicin (C.Sq.) 50 mg/ml 0.5 ml 50 g/ml 
BPE (in-house, -70
o
C)
€
 13 mg/ml (65mg) 1 vial 0.13 mg/ml 
Insulin (C.Sq.) 5 mg/ml 0.5 ml 5 g/ml 
Triiodothyronine (C.Sq.) 6.5 g/ml 0.5 ml 6.5 ng/ml 
Hydrocortisone (C.Sq.) 0.5 mg/ml 0.5 ml 0.5 g/ml 
rhEGF (C.Sq.) 0. 5 g/ml 0.5 ml 0.5 ng/ml 
Transferrin (C.Sq.) 10 mg/ml 0.5 ml 10 g/ml 
Epinephrin (C.Sq.) 0.5 mg/ml 0.5 ml 0.5 g/ml 
Retinoic Acid (in-house, -
70
o
C 
50 mM 0.5 ml 50 nM 
*Aliquots (Clonetics SingleQuot and in-house) are prepared such that adding the entire 
volume of 1 tube/vial will yield the correct final concentration in 500 ml of 50:50 
DMEM/BEBM Media. 
 
€
If no in house BPE is available, use 2.5 vials of BPE from SingleQuot Bullet Kit. 
 
C.Sq. = Clonetics SingleQuot, stored at -20
o
C in plastic storage bag 
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Protocol #11: NHBE Cell Harvest & Cryopreservation 
1. Aspirate media, rinse T-75 flasks with 8-10 ml PBS buffer. 
2. Added 6-8 ml of warm trypsin (thaw in 37°C water bath) to each T-75 flask. Incubated at 
37°C for 5 min, rocking flask every 1-2 minutes or until most of the cells have detached. 
3. Immediately added 5-10 ml of cold Trypsin Neutralization solution, serum-containing 
medium or pure serum to each flask. 
4. Transferred cell suspension to a 50 ml conical tubes. 
5. Rinsed flasks with 8-10 ml cold HBSS/ flask and added to conical tubes containing cell 
suspensions. 
6. Centrifuged at 1250 rpm for 5 minutes at 4°C in an refrigerated Eppendorpf table top 
centrifuge. 
7. Removed supernatant by gentle vacuum aspiration or pouring. 
8. Tapped tube to remove clumps prior to adding media to cells. 
9. Used ice-cold Expansion media (with high EGF, 25 ng/ml) to resuspend and wash cells. 
Pooled into one tube. 
10. Centrifuged cells again at 1250 rpm for 5 minutes at 4°C. 
11. Determine cell concentration and viability using Trypan Blue Exclusion Dye (20 µl dye + 
20 µl cell suspension). Counted with Bio-Rad automated cell counter. 
12. Resuspended cells to a concentration of 2.0 x 106-2.5 x106 live cells/ml in Cell freezing 
Solution (80% BEBM expansion media, 10% DMSO; 10 % Heat inactivated FBS). 
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13. Made 1 ml cell aliquots. Using 2.0 ml cryotubes with internal threading and silicon 
gasket. 
14. Placed cryotubes inside a cryopreservation cooler (purple rectangular or circle one); 
stored at -80°C, overnight. 
15. Transferred cells to liquid nitrogen storage the next morning and recorded in LN2 
logbook.   
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Appendix B 
Posters and Title Page from Presentations 
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